• CPNP’s CellProtect receives orphan drug designation from EC pharmaceutical-technology
    December 20, 2017
    CellProtect Nordic Pharmaceuticals’ (CPNP) therapy candidate CellProtect has received orphan drug designation from the European Commission (EC) to treat multiple myeloma.
  • Six new medicines endorsed for EU approval pharmatimes
    February 28, 2017
    Six new medicines, including the first hormone replacement therapy for a thyroid disorder, have been put forward for approval by the European Medicines Agency's Committee for Medicinal Products for Human Use.
PharmaSources Customer Service